avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Chd1
|
ENSMUSG00000023852.15 | Chd1 |
Pml
|
ENSMUSG00000036986.17 | Pml |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Chd1 | mm39_v1_chr17_+_15925205_15925256 | 0.64 | 2.5e-05 | Click! |
Pml | mm39_v1_chr9_-_58156935_58156969 | -0.32 | 5.9e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_-_161671421 | 16.35 |
ENSMUST00000033723.4
|
Syap1
|
synapse associated protein 1 |
chr12_+_110413677 | 13.21 |
ENSMUST00000220509.2
|
Ppp2r5c
|
protein phosphatase 2, regulatory subunit B', gamma |
chr2_-_70655997 | 11.95 |
ENSMUST00000038584.9
|
Tlk1
|
tousled-like kinase 1 |
chr11_-_106811185 | 11.72 |
ENSMUST00000167787.2
ENSMUST00000092517.9 |
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr17_+_64907697 | 11.14 |
ENSMUST00000086723.10
|
Man2a1
|
mannosidase 2, alpha 1 |
chr17_-_10538253 | 10.98 |
ENSMUST00000233828.2
ENSMUST00000233645.2 ENSMUST00000042296.9 |
Qk
|
quaking, KH domain containing RNA binding |
chr17_-_88372671 | 10.88 |
ENSMUST00000235112.2
ENSMUST00000005504.15 |
Fbxo11
|
F-box protein 11 |
chr2_+_109747984 | 10.71 |
ENSMUST00000046548.14
ENSMUST00000111037.3 |
Lgr4
|
leucine-rich repeat-containing G protein-coupled receptor 4 |
chr16_+_64672334 | 10.49 |
ENSMUST00000067744.8
|
Cggbp1
|
CGG triplet repeat binding protein 1 |
chr19_+_32734884 | 10.26 |
ENSMUST00000013807.8
|
Pten
|
phosphatase and tensin homolog |
chr14_-_45767421 | 9.92 |
ENSMUST00000150660.3
|
Fermt2
|
fermitin family member 2 |
chr15_-_3612703 | 9.82 |
ENSMUST00000069451.11
|
Ghr
|
growth hormone receptor |
chr2_+_18681812 | 9.71 |
ENSMUST00000028071.13
|
Bmi1
|
Bmi1 polycomb ring finger oncogene |
chr18_-_39623698 | 9.64 |
ENSMUST00000115567.8
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr1_-_10302895 | 9.48 |
ENSMUST00000088615.11
ENSMUST00000131556.2 |
Arfgef1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
chr13_-_9814467 | 9.40 |
ENSMUST00000154994.8
ENSMUST00000146039.2 ENSMUST00000110635.8 ENSMUST00000110638.8 |
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr14_+_57124028 | 9.36 |
ENSMUST00000223669.2
|
Zmym2
|
zinc finger, MYM-type 2 |
chr5_+_89034666 | 9.30 |
ENSMUST00000148750.8
|
Slc4a4
|
solute carrier family 4 (anion exchanger), member 4 |
chr13_-_49121461 | 9.22 |
ENSMUST00000060805.7
|
Fam120a
|
family with sequence similarity 120, member A |
chr1_-_52539395 | 9.16 |
ENSMUST00000186764.7
|
Nab1
|
Ngfi-A binding protein 1 |
chr5_-_96309600 | 8.91 |
ENSMUST00000129646.8
ENSMUST00000113005.9 ENSMUST00000154500.2 ENSMUST00000141383.8 |
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr6_-_145195903 | 8.80 |
ENSMUST00000111710.8
ENSMUST00000155145.2 ENSMUST00000032399.12 ENSMUST00000203147.3 |
Kras
|
Kirsten rat sarcoma viral oncogene homolog |
chr11_+_21189277 | 8.79 |
ENSMUST00000109578.8
ENSMUST00000006221.14 |
Vps54
|
VPS54 GARP complex subunit |
chr12_-_4527138 | 8.77 |
ENSMUST00000085814.5
|
Ncoa1
|
nuclear receptor coactivator 1 |
chr11_+_70735751 | 8.74 |
ENSMUST00000177731.8
ENSMUST00000108533.10 ENSMUST00000081362.13 ENSMUST00000178245.2 |
Rabep1
|
rabaptin, RAB GTPase binding effector protein 1 |
chr18_+_73706115 | 8.68 |
ENSMUST00000091852.5
|
Mex3c
|
mex3 RNA binding family member C |
chr10_+_42637479 | 8.53 |
ENSMUST00000019937.5
|
Sec63
|
SEC63-like (S. cerevisiae) |
chr1_-_80318028 | 8.45 |
ENSMUST00000164108.8
|
Cul3
|
cullin 3 |
chr14_-_45767575 | 8.41 |
ENSMUST00000045905.15
|
Fermt2
|
fermitin family member 2 |
chr13_+_75855695 | 8.36 |
ENSMUST00000222194.2
ENSMUST00000223535.2 ENSMUST00000222853.2 |
Ell2
|
elongation factor for RNA polymerase II 2 |
chr10_+_98750978 | 8.34 |
ENSMUST00000020107.8
|
Atp2b1
|
ATPase, Ca++ transporting, plasma membrane 1 |
chr4_-_104967032 | 8.32 |
ENSMUST00000030243.8
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr12_+_111005768 | 8.15 |
ENSMUST00000084968.14
|
Rcor1
|
REST corepressor 1 |
chr1_-_80318197 | 8.08 |
ENSMUST00000163119.8
|
Cul3
|
cullin 3 |
chr11_+_21041291 | 8.07 |
ENSMUST00000093290.12
|
Peli1
|
pellino 1 |
chr11_+_94102255 | 8.03 |
ENSMUST00000041589.6
|
Tob1
|
transducer of ErbB-2.1 |
chr18_+_64473091 | 7.96 |
ENSMUST00000175965.10
|
Onecut2
|
one cut domain, family member 2 |
chr11_-_6425877 | 7.93 |
ENSMUST00000179343.3
|
Purb
|
purine rich element binding protein B |
chr2_-_5719302 | 7.88 |
ENSMUST00000044009.14
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr5_-_123822351 | 7.87 |
ENSMUST00000111564.8
ENSMUST00000063905.12 |
Clip1
|
CAP-GLY domain containing linker protein 1 |
chr5_+_43390513 | 7.79 |
ENSMUST00000166713.9
ENSMUST00000169035.8 ENSMUST00000114065.9 |
Cpeb2
|
cytoplasmic polyadenylation element binding protein 2 |
chr4_+_129713991 | 7.73 |
ENSMUST00000030578.14
|
Ptp4a2
|
protein tyrosine phosphatase 4a2 |
chr13_-_101904662 | 7.73 |
ENSMUST00000055518.13
|
Pik3r1
|
phosphoinositide-3-kinase regulatory subunit 1 |
chr14_-_31552608 | 7.70 |
ENSMUST00000014640.9
|
Ankrd28
|
ankyrin repeat domain 28 |
chr11_-_49603501 | 7.54 |
ENSMUST00000020624.7
ENSMUST00000145353.8 |
Cnot6
|
CCR4-NOT transcription complex, subunit 6 |
chr10_-_7831657 | 7.51 |
ENSMUST00000147938.2
|
Tab2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
chr9_+_108569489 | 7.49 |
ENSMUST00000195405.6
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr5_-_123822338 | 7.44 |
ENSMUST00000111561.8
|
Clip1
|
CAP-GLY domain containing linker protein 1 |
chr14_-_31552335 | 7.39 |
ENSMUST00000228037.2
|
Ankrd28
|
ankyrin repeat domain 28 |
chr17_-_64638887 | 7.39 |
ENSMUST00000172818.8
|
Pja2
|
praja ring finger ubiquitin ligase 2 |
chr16_+_43993599 | 7.39 |
ENSMUST00000119746.8
ENSMUST00000088356.10 ENSMUST00000169582.3 |
Usf3
|
upstream transcription factor family member 3 |
chr4_+_53440516 | 7.37 |
ENSMUST00000107651.9
ENSMUST00000107647.8 |
Slc44a1
|
solute carrier family 44, member 1 |
chr10_-_118705029 | 7.34 |
ENSMUST00000004281.10
|
Dyrk2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
chrX_+_12937714 | 7.18 |
ENSMUST00000169594.9
ENSMUST00000089302.11 |
Usp9x
|
ubiquitin specific peptidase 9, X chromosome |
chr11_-_69260203 | 7.16 |
ENSMUST00000092971.13
ENSMUST00000108661.8 |
Chd3
|
chromodomain helicase DNA binding protein 3 |
chr17_-_64638814 | 7.14 |
ENSMUST00000172733.2
|
Pja2
|
praja ring finger ubiquitin ligase 2 |
chr17_-_88372315 | 7.13 |
ENSMUST00000235056.2
ENSMUST00000130379.9 |
Fbxo11
|
F-box protein 11 |
chr4_+_15265798 | 7.13 |
ENSMUST00000062684.9
|
Tmem64
|
transmembrane protein 64 |
chr1_-_136273436 | 7.10 |
ENSMUST00000192001.6
ENSMUST00000192314.2 |
Camsap2
|
calmodulin regulated spectrin-associated protein family, member 2 |
chr13_+_46822992 | 7.09 |
ENSMUST00000099547.4
|
Fam8a1
|
family with sequence similarity 8, member A1 |
chr10_-_17823736 | 7.09 |
ENSMUST00000037879.8
|
Heca
|
hdc homolog, cell cycle regulator |
chr11_-_106504196 | 7.05 |
ENSMUST00000128933.2
|
Tex2
|
testis expressed gene 2 |
chr3_+_16237371 | 6.88 |
ENSMUST00000108345.9
ENSMUST00000191774.6 ENSMUST00000108346.5 |
Ythdf3
|
YTH N6-methyladenosine RNA binding protein 3 |
chr14_-_61677258 | 6.87 |
ENSMUST00000022496.9
|
Kpna3
|
karyopherin (importin) alpha 3 |
chr5_-_96309849 | 6.82 |
ENSMUST00000155901.8
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr10_-_63174801 | 6.79 |
ENSMUST00000020257.13
ENSMUST00000177694.8 ENSMUST00000105442.3 |
Sirt1
|
sirtuin 1 |
chr2_-_72810754 | 6.78 |
ENSMUST00000066003.7
|
Sp3
|
trans-acting transcription factor 3 |
chrX_-_59449137 | 6.73 |
ENSMUST00000033480.13
ENSMUST00000101527.3 |
Atp11c
|
ATPase, class VI, type 11C |
chr12_-_69728572 | 6.73 |
ENSMUST00000183277.8
ENSMUST00000035773.14 |
Sos2
|
SOS Ras/Rho guanine nucleotide exchange factor 2 |
chr1_-_84817022 | 6.61 |
ENSMUST00000189496.7
ENSMUST00000027421.13 ENSMUST00000186894.7 |
Trip12
|
thyroid hormone receptor interactor 12 |
chr15_-_3612628 | 6.55 |
ENSMUST00000110698.9
|
Ghr
|
growth hormone receptor |
chr1_+_85721132 | 6.51 |
ENSMUST00000113360.8
ENSMUST00000126962.3 |
Cab39
|
calcium binding protein 39 |
chr8_+_88925821 | 6.51 |
ENSMUST00000066748.10
ENSMUST00000119033.8 ENSMUST00000118952.8 |
Tent4b
|
terminal nucleotidyltransferase 4B |
chr9_+_108569315 | 6.48 |
ENSMUST00000035220.12
|
Prkar2a
|
protein kinase, cAMP dependent regulatory, type II alpha |
chr15_+_54434576 | 6.46 |
ENSMUST00000025356.4
|
Mal2
|
mal, T cell differentiation protein 2 |
chr5_-_21260878 | 6.40 |
ENSMUST00000030556.8
|
Ptpn12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr17_+_6157154 | 6.40 |
ENSMUST00000149756.8
|
Tulp4
|
tubby like protein 4 |
chr3_+_88857929 | 6.37 |
ENSMUST00000186583.7
|
Ash1l
|
ASH1 like histone lysine methyltransferase |
chr15_-_31531122 | 6.34 |
ENSMUST00000090227.6
|
Marchf6
|
membrane associated ring-CH-type finger 6 |
chr15_-_10470575 | 6.32 |
ENSMUST00000136591.8
|
Dnajc21
|
DnaJ heat shock protein family (Hsp40) member C21 |
chr14_-_57049173 | 6.31 |
ENSMUST00000039812.16
ENSMUST00000111285.9 |
Zmym5
|
zinc finger, MYM-type 5 |
chr2_-_104647041 | 6.30 |
ENSMUST00000117237.2
ENSMUST00000231375.2 |
Qser1
|
glutamine and serine rich 1 |
chr14_-_45767232 | 6.28 |
ENSMUST00000149723.2
|
Fermt2
|
fermitin family member 2 |
chr3_-_105708601 | 6.28 |
ENSMUST00000197094.5
ENSMUST00000198004.2 |
Rap1a
|
RAS-related protein 1a |
chr19_-_59334172 | 6.26 |
ENSMUST00000099274.4
|
Pdzd8
|
PDZ domain containing 8 |
chr6_+_71248655 | 6.25 |
ENSMUST00000204436.3
ENSMUST00000205123.2 |
Krcc1
|
lysine-rich coiled-coil 1 |
chr4_+_129714494 | 6.24 |
ENSMUST00000165853.2
|
Ptp4a2
|
protein tyrosine phosphatase 4a2 |
chr16_-_64672011 | 6.20 |
ENSMUST00000207826.2
|
Zfp654
|
zinc finger protein 654 |
chr8_-_85526653 | 6.19 |
ENSMUST00000126806.2
ENSMUST00000076715.13 |
Nfix
|
nuclear factor I/X |
chr6_-_100264439 | 6.17 |
ENSMUST00000101118.4
|
Rybp
|
RING1 and YY1 binding protein |
chr17_-_79328157 | 6.13 |
ENSMUST00000168887.8
ENSMUST00000119284.8 |
Prkd3
|
protein kinase D3 |
chr3_-_105708632 | 6.07 |
ENSMUST00000090678.11
|
Rap1a
|
RAS-related protein 1a |
chr17_+_13980764 | 6.05 |
ENSMUST00000139347.8
ENSMUST00000156591.8 ENSMUST00000170827.9 ENSMUST00000139666.8 ENSMUST00000137708.8 ENSMUST00000137784.8 ENSMUST00000150848.8 |
Afdn
|
afadin, adherens junction formation factor |
chr18_-_16942289 | 6.04 |
ENSMUST00000025166.14
|
Cdh2
|
cadherin 2 |
chr17_+_46694646 | 6.02 |
ENSMUST00000113481.9
ENSMUST00000138127.8 |
Zfp318
|
zinc finger protein 318 |
chr14_+_34396079 | 5.94 |
ENSMUST00000169910.8
ENSMUST00000090027.11 |
Wapl
|
WAPL cohesin release factor |
chr2_-_80411578 | 5.91 |
ENSMUST00000028386.12
|
Nckap1
|
NCK-associated protein 1 |
chr13_-_9814901 | 5.88 |
ENSMUST00000223421.2
ENSMUST00000128658.8 |
Zmynd11
|
zinc finger, MYND domain containing 11 |
chr4_+_20008357 | 5.85 |
ENSMUST00000117632.8
ENSMUST00000098244.2 |
Ttpa
|
tocopherol (alpha) transfer protein |
chr2_-_72810782 | 5.82 |
ENSMUST00000102689.10
|
Sp3
|
trans-acting transcription factor 3 |
chr1_+_59802543 | 5.81 |
ENSMUST00000087435.7
|
Bmpr2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
chr7_-_16348862 | 5.80 |
ENSMUST00000171937.2
ENSMUST00000075845.11 |
Arhgap35
|
Rho GTPase activating protein 35 |
chr17_-_80787398 | 5.78 |
ENSMUST00000068714.7
|
Sos1
|
SOS Ras/Rac guanine nucleotide exchange factor 1 |
chr8_+_23349543 | 5.78 |
ENSMUST00000238975.2
ENSMUST00000110696.8 ENSMUST00000044331.7 |
Kat6a
|
K(lysine) acetyltransferase 6A |
chr6_+_54793894 | 5.72 |
ENSMUST00000079869.13
|
Znrf2
|
zinc and ring finger 2 |
chr2_-_37593287 | 5.71 |
ENSMUST00000072186.12
|
Strbp
|
spermatid perinuclear RNA binding protein |
chr15_+_41652777 | 5.69 |
ENSMUST00000230778.2
ENSMUST00000022918.15 ENSMUST00000090095.13 |
Oxr1
|
oxidation resistance 1 |
chr17_+_53873964 | 5.68 |
ENSMUST00000000724.15
|
Kat2b
|
K(lysine) acetyltransferase 2B |
chr5_+_23639432 | 5.68 |
ENSMUST00000094962.9
ENSMUST00000115128.8 |
Kmt2e
|
lysine (K)-specific methyltransferase 2E |
chr5_-_65855199 | 5.67 |
ENSMUST00000031104.7
|
Pds5a
|
PDS5 cohesin associated factor A |
chr8_-_105122397 | 5.66 |
ENSMUST00000179802.2
|
Cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
chr11_-_106811507 | 5.64 |
ENSMUST00000103067.10
|
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chr11_+_30721726 | 5.64 |
ENSMUST00000041231.14
|
Psme4
|
proteasome (prosome, macropain) activator subunit 4 |
chrX_+_76554608 | 5.63 |
ENSMUST00000088217.12
|
Tbl1x
|
transducin (beta)-like 1 X-linked |
chr18_+_24338729 | 5.61 |
ENSMUST00000170243.8
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1 |
chr3_+_136375839 | 5.58 |
ENSMUST00000070198.14
|
Ppp3ca
|
protein phosphatase 3, catalytic subunit, alpha isoform |
chr6_+_4600839 | 5.57 |
ENSMUST00000015333.12
ENSMUST00000181734.8 |
Casd1
|
CAS1 domain containing 1 |
chr9_-_94420128 | 5.57 |
ENSMUST00000113028.2
|
Dipk2a
|
divergent protein kinase domain 2A |
chr1_-_30912662 | 5.57 |
ENSMUST00000186733.7
|
Phf3
|
PHD finger protein 3 |
chr9_+_44516140 | 5.51 |
ENSMUST00000170489.2
ENSMUST00000217034.2 |
Ddx6
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 |
chr2_+_163836880 | 5.51 |
ENSMUST00000018470.10
|
Ywhab
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
chr2_+_58457370 | 5.47 |
ENSMUST00000071543.12
|
Upp2
|
uridine phosphorylase 2 |
chr3_+_34074222 | 5.45 |
ENSMUST00000167354.8
ENSMUST00000198051.5 ENSMUST00000197694.5 ENSMUST00000200392.5 |
Fxr1
|
fragile X mental retardation gene 1, autosomal homolog |
chr16_-_30207348 | 5.44 |
ENSMUST00000061350.13
ENSMUST00000100013.9 |
Atp13a3
|
ATPase type 13A3 |
chr4_-_118148471 | 5.44 |
ENSMUST00000222620.2
|
Ptprf
|
protein tyrosine phosphatase, receptor type, F |
chr6_-_71417607 | 5.42 |
ENSMUST00000002292.15
|
Rmnd5a
|
required for meiotic nuclear division 5 homolog A |
chr4_-_59549243 | 5.39 |
ENSMUST00000173699.8
ENSMUST00000173884.8 ENSMUST00000102883.11 ENSMUST00000174586.8 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr2_-_80411724 | 5.37 |
ENSMUST00000111760.3
|
Nckap1
|
NCK-associated protein 1 |
chr9_+_25163735 | 5.37 |
ENSMUST00000115272.9
ENSMUST00000165594.4 |
Septin7
|
septin 7 |
chr1_-_84817000 | 5.36 |
ENSMUST00000186648.7
|
Trip12
|
thyroid hormone receptor interactor 12 |
chr15_-_8473918 | 5.35 |
ENSMUST00000052965.8
|
Nipbl
|
NIPBL cohesin loading factor |
chr3_+_121746862 | 5.33 |
ENSMUST00000037958.14
ENSMUST00000196904.5 |
Arhgap29
|
Rho GTPase activating protein 29 |
chr11_-_106503754 | 5.31 |
ENSMUST00000042780.14
|
Tex2
|
testis expressed gene 2 |
chr18_+_53995260 | 5.31 |
ENSMUST00000237880.2
|
Csnk1g3
|
casein kinase 1, gamma 3 |
chr2_+_48704121 | 5.30 |
ENSMUST00000063886.4
|
Acvr2a
|
activin receptor IIA |
chr18_+_24338993 | 5.29 |
ENSMUST00000164998.8
|
Galnt1
|
polypeptide N-acetylgalactosaminyltransferase 1 |
chr5_+_124583524 | 5.29 |
ENSMUST00000100709.7
|
Kmt5a
|
lysine methyltransferase 5A |
chr18_+_5591864 | 5.28 |
ENSMUST00000025081.13
ENSMUST00000159390.8 |
Zeb1
|
zinc finger E-box binding homeobox 1 |
chr15_+_41652329 | 5.27 |
ENSMUST00000170127.9
|
Oxr1
|
oxidation resistance 1 |
chr18_-_39622829 | 5.25 |
ENSMUST00000025300.13
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr14_-_103220066 | 5.24 |
ENSMUST00000184744.2
|
Kctd12
|
potassium channel tetramerisation domain containing 12 |
chr10_-_123032821 | 5.23 |
ENSMUST00000219619.2
ENSMUST00000020334.9 |
Usp15
|
ubiquitin specific peptidase 15 |
chr1_+_191449946 | 5.20 |
ENSMUST00000133076.7
ENSMUST00000110855.8 |
Lpgat1
|
lysophosphatidylglycerol acyltransferase 1 |
chr4_-_59549314 | 5.20 |
ENSMUST00000148331.9
ENSMUST00000030076.12 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr5_-_50216249 | 5.19 |
ENSMUST00000030971.7
|
Adgra3
|
adhesion G protein-coupled receptor A3 |
chr5_-_88823472 | 5.18 |
ENSMUST00000113234.8
ENSMUST00000153565.8 |
Grsf1
|
G-rich RNA sequence binding factor 1 |
chr16_-_46317318 | 5.16 |
ENSMUST00000023335.13
ENSMUST00000023334.15 |
Nectin3
|
nectin cell adhesion molecule 3 |
chr5_+_73648368 | 5.15 |
ENSMUST00000113558.8
ENSMUST00000063882.12 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr4_-_4793274 | 5.15 |
ENSMUST00000084949.3
|
Bpnt2
|
3'(2'), 5'-bisphosphate nucleotidase 2 |
chr7_+_114014509 | 5.08 |
ENSMUST00000032909.9
|
Pde3b
|
phosphodiesterase 3B, cGMP-inhibited |
chr6_+_100810566 | 5.08 |
ENSMUST00000063854.7
|
Ppp4r2
|
protein phosphatase 4, regulatory subunit 2 |
chr11_-_84761009 | 5.07 |
ENSMUST00000154915.9
|
Ggnbp2
|
gametogenetin binding protein 2 |
chr11_+_53241561 | 5.07 |
ENSMUST00000060945.12
|
Aff4
|
AF4/FMR2 family, member 4 |
chr7_-_34088886 | 5.07 |
ENSMUST00000155256.8
|
Lsm14a
|
LSM14A mRNA processing body assembly factor |
chr5_+_108416763 | 5.06 |
ENSMUST00000031190.5
|
Dr1
|
down-regulator of transcription 1 |
chr6_-_119825081 | 5.05 |
ENSMUST00000183703.8
ENSMUST00000183911.8 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr7_-_67022520 | 5.05 |
ENSMUST00000156690.8
ENSMUST00000107476.8 ENSMUST00000076325.12 ENSMUST00000032776.15 ENSMUST00000133074.2 |
Mef2a
|
myocyte enhancer factor 2A |
chr13_-_108026590 | 5.04 |
ENSMUST00000225822.4
ENSMUST00000225197.3 |
Zswim6
|
zinc finger SWIM-type containing 6 |
chr2_+_90770742 | 5.00 |
ENSMUST00000005643.14
ENSMUST00000111451.10 ENSMUST00000177642.8 ENSMUST00000068726.13 ENSMUST00000068747.14 |
Celf1
|
CUGBP, Elav-like family member 1 |
chrX_+_41156713 | 5.00 |
ENSMUST00000115094.8
|
Xiap
|
X-linked inhibitor of apoptosis |
chr11_-_85030761 | 4.99 |
ENSMUST00000108075.9
|
Usp32
|
ubiquitin specific peptidase 32 |
chr11_-_120551426 | 4.96 |
ENSMUST00000106177.8
|
Notum
|
notum palmitoleoyl-protein carboxylesterase |
chr8_-_85526972 | 4.95 |
ENSMUST00000099070.10
|
Nfix
|
nuclear factor I/X |
chrX_+_70408351 | 4.92 |
ENSMUST00000146213.8
ENSMUST00000114601.8 ENSMUST00000015358.8 |
Mtmr1
|
myotubularin related protein 1 |
chr4_+_102971581 | 4.91 |
ENSMUST00000106858.8
|
Mier1
|
MEIR1 treanscription regulator |
chr2_+_69727563 | 4.90 |
ENSMUST00000055758.16
ENSMUST00000112251.9 |
Ubr3
|
ubiquitin protein ligase E3 component n-recognin 3 |
chr18_+_7868823 | 4.90 |
ENSMUST00000171042.8
ENSMUST00000166378.8 ENSMUST00000074919.11 |
Wac
|
WW domain containing adaptor with coiled-coil |
chr14_-_34224620 | 4.90 |
ENSMUST00000049005.15
|
Bmpr1a
|
bone morphogenetic protein receptor, type 1A |
chr3_+_103187162 | 4.89 |
ENSMUST00000106860.6
|
Trim33
|
tripartite motif-containing 33 |
chr2_+_60040231 | 4.89 |
ENSMUST00000102748.11
|
Marchf7
|
membrane associated ring-CH-type finger 7 |
chr7_+_111622675 | 4.88 |
ENSMUST00000106653.4
ENSMUST00000215510.2 ENSMUST00000210309.2 |
Usp47
|
ubiquitin specific peptidase 47 |
chr9_+_118335294 | 4.85 |
ENSMUST00000084820.6
|
Golga4
|
golgi autoantigen, golgin subfamily a, 4 |
chr6_+_47430808 | 4.85 |
ENSMUST00000146200.8
|
Cul1
|
cullin 1 |
chrX_+_139565657 | 4.81 |
ENSMUST00000112990.8
ENSMUST00000112988.8 |
Mid2
|
midline 2 |
chr5_-_88823989 | 4.81 |
ENSMUST00000078945.12
|
Grsf1
|
G-rich RNA sequence binding factor 1 |
chr2_+_4722636 | 4.80 |
ENSMUST00000184139.8
ENSMUST00000115022.8 |
Bend7
|
BEN domain containing 7 |
chr15_-_90934021 | 4.77 |
ENSMUST00000109287.4
ENSMUST00000067205.16 ENSMUST00000088614.13 |
Kif21a
|
kinesin family member 21A |
chr9_+_100525501 | 4.77 |
ENSMUST00000146312.8
ENSMUST00000129269.8 |
Stag1
|
stromal antigen 1 |
chr15_+_12321558 | 4.76 |
ENSMUST00000226517.2
|
Golph3
|
golgi phosphoprotein 3 |
chr8_+_40964818 | 4.76 |
ENSMUST00000098817.4
|
Vps37a
|
vacuolar protein sorting 37A |
chr13_+_51254852 | 4.76 |
ENSMUST00000095797.6
|
Spin1
|
spindlin 1 |
chr7_-_65020655 | 4.75 |
ENSMUST00000032729.8
|
Tjp1
|
tight junction protein 1 |
chr7_-_110213968 | 4.75 |
ENSMUST00000166020.8
ENSMUST00000171218.8 ENSMUST00000033058.14 ENSMUST00000164759.8 |
Sbf2
|
SET binding factor 2 |
chr5_+_88712840 | 4.75 |
ENSMUST00000196894.5
ENSMUST00000198965.5 |
Rufy3
|
RUN and FYVE domain containing 3 |
chrX_-_69408627 | 4.75 |
ENSMUST00000101509.9
|
Ids
|
iduronate 2-sulfatase |
chr9_+_64940004 | 4.74 |
ENSMUST00000167773.2
|
Dpp8
|
dipeptidylpeptidase 8 |
chr16_-_95883588 | 4.74 |
ENSMUST00000099502.9
ENSMUST00000023631.17 ENSMUST00000232755.2 |
Brwd1
|
bromodomain and WD repeat domain containing 1 |
chr4_-_58911902 | 4.74 |
ENSMUST00000134848.2
ENSMUST00000107557.9 ENSMUST00000149301.8 |
Ecpas
|
Ecm29 proteasome adaptor and scaffold |
chr9_+_100956145 | 4.73 |
ENSMUST00000189616.2
|
Msl2
|
MSL complex subunit 2 |
chr19_+_57599452 | 4.72 |
ENSMUST00000077282.7
|
Atrnl1
|
attractin like 1 |
chr3_+_35808269 | 4.72 |
ENSMUST00000029257.15
|
Atp11b
|
ATPase, class VI, type 11B |
chr5_-_65855511 | 4.72 |
ENSMUST00000201948.4
|
Pds5a
|
PDS5 cohesin associated factor A |
chr14_-_20596580 | 4.71 |
ENSMUST00000022355.11
ENSMUST00000161445.8 ENSMUST00000159027.8 |
Ppp3cb
|
protein phosphatase 3, catalytic subunit, beta isoform |
chr9_+_72569755 | 4.68 |
ENSMUST00000184450.8
ENSMUST00000183375.8 |
Nedd4
|
neural precursor cell expressed, developmentally down-regulated 4 |
chr15_+_12321620 | 4.68 |
ENSMUST00000228671.2
|
Golph3
|
golgi phosphoprotein 3 |
chr9_+_77661808 | 4.65 |
ENSMUST00000034905.9
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr7_-_65020955 | 4.65 |
ENSMUST00000102592.10
|
Tjp1
|
tight junction protein 1 |
chr11_-_120551494 | 4.65 |
ENSMUST00000106178.9
|
Notum
|
notum palmitoleoyl-protein carboxylesterase |
chr10_+_95776543 | 4.64 |
ENSMUST00000053484.8
|
Eea1
|
early endosome antigen 1 |
chr1_+_166081664 | 4.63 |
ENSMUST00000111416.7
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.1 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
3.5 | 10.6 | GO:0009955 | adaxial/abaxial pattern specification(GO:0009955) regulation of adaxial/abaxial pattern formation(GO:2000011) |
3.4 | 10.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
3.4 | 10.2 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
3.3 | 13.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
3.3 | 13.1 | GO:1904412 | regulation of cardiac ventricle development(GO:1904412) |
3.1 | 15.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
3.1 | 21.5 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
3.0 | 15.0 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
3.0 | 17.7 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
2.9 | 14.6 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
2.9 | 8.7 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
2.7 | 19.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.7 | 8.1 | GO:0060936 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
2.6 | 30.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.5 | 7.5 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
2.5 | 12.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
2.4 | 9.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
2.3 | 21.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.3 | 7.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
2.3 | 9.2 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
2.3 | 16.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
2.3 | 13.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.2 | 6.7 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
2.2 | 8.7 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
2.2 | 6.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
2.2 | 6.5 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
2.1 | 6.4 | GO:0035037 | sperm entry(GO:0035037) |
2.1 | 6.4 | GO:1903699 | tarsal gland development(GO:1903699) |
2.1 | 8.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
2.1 | 14.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
2.0 | 14.3 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.0 | 4.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.0 | 8.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
2.0 | 22.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.0 | 8.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
2.0 | 7.9 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
2.0 | 6.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.0 | 2.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.9 | 5.8 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
1.9 | 7.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.9 | 7.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.9 | 7.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
1.9 | 5.6 | GO:0035603 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
1.8 | 11.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
1.8 | 14.5 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
1.8 | 10.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.8 | 7.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
1.8 | 5.4 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
1.8 | 5.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
1.8 | 1.8 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
1.8 | 8.8 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
1.7 | 5.2 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.7 | 12.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.7 | 8.5 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
1.7 | 5.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.7 | 10.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.7 | 6.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.7 | 10.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.7 | 5.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.7 | 9.9 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.6 | 6.5 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.6 | 7.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.6 | 3.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
1.5 | 4.6 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.5 | 15.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.5 | 19.7 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.5 | 13.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.5 | 4.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.5 | 6.0 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.5 | 4.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.5 | 7.3 | GO:0070178 | D-serine metabolic process(GO:0070178) |
1.5 | 4.4 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
1.4 | 4.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.4 | 5.7 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.4 | 7.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.4 | 9.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.4 | 6.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.4 | 4.1 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.4 | 4.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.3 | 2.7 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
1.3 | 10.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.3 | 1.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
1.3 | 8.0 | GO:0016266 | O-glycan processing(GO:0016266) |
1.3 | 7.9 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
1.3 | 19.8 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.3 | 3.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
1.3 | 3.9 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.3 | 9.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.3 | 3.9 | GO:0061198 | fungiform papilla formation(GO:0061198) |
1.3 | 6.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.3 | 7.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.3 | 7.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.3 | 8.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.3 | 7.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.3 | 7.6 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.2 | 8.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
1.2 | 4.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.2 | 3.6 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
1.2 | 4.7 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.2 | 4.7 | GO:0030026 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.2 | 5.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.1 | 3.4 | GO:1903413 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
1.1 | 5.7 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
1.1 | 5.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.1 | 7.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 3.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.1 | 10.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.1 | 1.1 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.1 | 3.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.1 | 4.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.1 | 2.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
1.1 | 3.3 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.1 | 2.2 | GO:0002188 | translation reinitiation(GO:0002188) |
1.1 | 14.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.1 | 11.9 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 2.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.1 | 11.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
1.1 | 3.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
1.1 | 3.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 31.6 | GO:0006491 | N-glycan processing(GO:0006491) |
1.1 | 3.2 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
1.1 | 5.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 4.2 | GO:0030091 | protein repair(GO:0030091) |
1.0 | 3.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
1.0 | 4.2 | GO:0080163 | regulation of protein serine/threonine phosphatase activity(GO:0080163) |
1.0 | 7.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.0 | 6.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.0 | 4.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
1.0 | 4.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.0 | 5.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.0 | 1.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.0 | 2.9 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
1.0 | 8.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.0 | 1.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
1.0 | 9.7 | GO:0051665 | membrane raft localization(GO:0051665) |
1.0 | 6.7 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
1.0 | 3.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.0 | 3.8 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
1.0 | 3.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.0 | 3.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.0 | 2.9 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
1.0 | 4.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.9 | 2.8 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.9 | 7.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 6.6 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.9 | 24.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.9 | 3.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.9 | 2.8 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.9 | 5.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 4.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.9 | 3.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.9 | 13.0 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.9 | 0.9 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.9 | 3.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.9 | 2.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.9 | 4.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 12.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.9 | 16.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.9 | 7.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.9 | 6.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.9 | 7.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.9 | 15.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.9 | 0.9 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.9 | 2.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.9 | 3.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.9 | 5.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 2.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.9 | 8.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.9 | 7.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.9 | 2.6 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.9 | 4.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 9.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 4.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.8 | 2.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.8 | 3.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.8 | 4.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 0.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.8 | 1.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.8 | 9.9 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.8 | 9.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 16.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.8 | 0.8 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.8 | 4.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 36.2 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.8 | 3.2 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.8 | 6.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.8 | 4.0 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.8 | 15.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.8 | 3.9 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.8 | 1.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.8 | 2.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.8 | 10.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.8 | 1.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.8 | 4.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.8 | 3.1 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.8 | 3.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.8 | 2.3 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.8 | 4.6 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 3.8 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.8 | 1.5 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.8 | 0.8 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) |
0.8 | 3.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.8 | 4.6 | GO:0015871 | choline transport(GO:0015871) |
0.8 | 2.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.8 | 2.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.8 | 6.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 3.0 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.8 | 3.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.7 | 3.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.7 | 6.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.7 | 1.5 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.7 | 2.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 2.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.7 | 1.5 | GO:0035627 | ceramide transport(GO:0035627) |
0.7 | 3.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 3.7 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.7 | 0.7 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.7 | 7.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.7 | 2.2 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.7 | 10.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.7 | 1.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.7 | 15.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.7 | 2.2 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.7 | 5.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.7 | 0.7 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.7 | 2.9 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.7 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.7 | 2.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 3.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.7 | 2.1 | GO:0016598 | protein arginylation(GO:0016598) |
0.7 | 4.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.7 | 2.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.7 | 13.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 2.8 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.7 | 7.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 2.7 | GO:0003017 | lymph circulation(GO:0003017) |
0.7 | 3.4 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.7 | 2.0 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.7 | 3.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 1.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.7 | 5.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.7 | 2.7 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.7 | 2.0 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.7 | 3.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.7 | 2.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.7 | 2.0 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.7 | 5.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.7 | 6.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.7 | 7.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.7 | 5.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 2.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.7 | 2.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 1.9 | GO:0021682 | nerve maturation(GO:0021682) |
0.6 | 2.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.6 | 2.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.6 | 3.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 0.6 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.6 | 5.7 | GO:0006983 | ER overload response(GO:0006983) |
0.6 | 7.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.6 | 5.1 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.6 | 6.4 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.6 | 5.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.6 | 1.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.6 | 3.8 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 17.7 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.6 | 1.9 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.6 | 3.7 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.6 | 3.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.6 | 6.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 5.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 1.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 8.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.6 | 7.3 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.6 | 0.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.6 | 1.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.6 | 1.8 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.6 | 1.8 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.6 | 14.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 1.8 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.6 | 5.9 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.6 | 2.4 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.6 | 5.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 4.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.6 | 4.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 1.7 | GO:0014889 | muscle atrophy(GO:0014889) |
0.6 | 1.7 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
0.6 | 0.6 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.6 | 8.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.6 | 4.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.6 | 2.3 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.6 | 2.8 | GO:0010157 | response to chlorate(GO:0010157) |
0.6 | 9.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.6 | 0.6 | GO:1904349 | positive regulation of small intestine smooth muscle contraction(GO:1904349) |
0.6 | 0.6 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.6 | 6.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.6 | 1.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 0.6 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.5 | 8.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.5 | 3.8 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.5 | 4.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.5 | 2.2 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.5 | 3.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.5 | 1.6 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.5 | 2.2 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.5 | 3.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 5.9 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.5 | 2.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.5 | 4.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 1.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 15.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 3.2 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.5 | 1.6 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.5 | 1.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.5 | 2.6 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.5 | 1.6 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.5 | 0.5 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.5 | 2.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.5 | 1.1 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.5 | 3.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 5.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.5 | 2.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.5 | 3.6 | GO:0061709 | reticulophagy(GO:0061709) |
0.5 | 1.6 | GO:2000845 | positive regulation of androgen secretion(GO:2000836) positive regulation of testosterone secretion(GO:2000845) |
0.5 | 1.6 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.5 | 16.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 2.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 9.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.5 | 1.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 0.5 | GO:0051977 | lysophospholipid transport(GO:0051977) |
0.5 | 3.0 | GO:1902988 | regulation of neuronal signal transduction(GO:1902847) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.5 | 2.0 | GO:0097274 | urea homeostasis(GO:0097274) |
0.5 | 2.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.5 | 8.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 6.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 3.5 | GO:0070836 | caveola assembly(GO:0070836) |
0.5 | 14.0 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.5 | 4.5 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.5 | 15.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.5 | 1.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 1.0 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.5 | 2.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.5 | 1.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 6.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.5 | 0.5 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.5 | 18.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 3.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 3.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 7.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.5 | 1.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.5 | 5.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.5 | 3.9 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.5 | 2.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 5.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 2.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.5 | 1.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 3.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 2.8 | GO:0035860 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.5 | 0.5 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.5 | 6.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.5 | 3.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.5 | 7.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.5 | 3.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.5 | 10.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 4.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.5 | 1.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 7.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 1.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.5 | 0.9 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.5 | 10.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 0.9 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.4 | 5.8 | GO:0060613 | fat pad development(GO:0060613) |
0.4 | 2.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 4.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 1.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.4 | 7.9 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.4 | 0.4 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.4 | 15.3 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 5.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 3.5 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 2.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.4 | 0.9 | GO:0072717 | response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
0.4 | 1.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 1.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.3 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.4 | 2.5 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.4 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.4 | 0.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.4 | 3.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 10.8 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.4 | 0.8 | GO:0061009 | common bile duct development(GO:0061009) |
0.4 | 2.1 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.4 | 5.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 1.2 | GO:0031591 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.4 | 0.8 | GO:0021561 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.4 | 2.5 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 0.4 | GO:0035935 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) regulation of testosterone secretion(GO:2000843) |
0.4 | 7.3 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 3.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 11.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.4 | 2.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.4 | 0.4 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.4 | 5.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.2 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.4 | 12.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 3.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.8 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.4 | 1.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.4 | 5.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.4 | 1.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 | 4.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 0.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 1.5 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.4 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 4.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 1.1 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.4 | 4.9 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.4 | 1.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.4 | 3.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 1.9 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.4 | 2.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.4 | 2.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 5.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 2.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 1.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 3.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 0.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.4 | 0.7 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.4 | 1.5 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 0.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 1.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.4 | 2.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 4.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.4 | 14.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 3.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 0.7 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 2.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 2.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.4 | 3.9 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 0.7 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.4 | 1.8 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.4 | 6.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.4 | 1.1 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.4 | 6.4 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.4 | 1.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 2.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 13.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 0.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 1.4 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 0.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.3 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.3 | 1.0 | GO:0015734 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
0.3 | 1.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 2.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 0.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.3 | 2.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 3.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 2.0 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 6.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.3 | 3.9 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 3.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.3 | 1.0 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.3 | 2.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 0.3 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 2.8 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.3 | 1.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.3 | 6.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 3.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 0.9 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.3 | 0.3 | GO:0070989 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) oxidative demethylation(GO:0070989) |
0.3 | 2.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 1.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 1.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.3 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 3.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.3 | 1.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 2.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 2.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 1.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 3.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 2.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.3 | 1.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 1.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.3 | 0.9 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.3 | 0.3 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 0.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.3 | 2.1 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 1.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 1.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 0.6 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.3 | 50.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 1.2 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.3 | 1.2 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.3 | 2.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.9 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.3 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 1.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 2.6 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 1.4 | GO:1904171 | negative regulation of bleb assembly(GO:1904171) |
0.3 | 1.7 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.3 | 1.1 | GO:1904247 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.3 | 1.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 6.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 0.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.3 | 0.8 | GO:0042726 | positive regulation of NAD(P)H oxidase activity(GO:0033864) flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.3 | 3.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 0.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 2.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.3 | 0.8 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.3 | 1.4 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.3 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 2.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 5.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 1.4 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.8 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.3 | 0.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 0.3 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.3 | 12.4 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 2.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 1.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.3 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.5 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.3 | 0.8 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.8 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.3 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 1.3 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.3 | 0.8 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.3 | 2.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 3.9 | GO:0007343 | egg activation(GO:0007343) |
0.3 | 3.1 | GO:0072189 | ureter development(GO:0072189) |
0.3 | 0.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 4.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 2.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 2.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.7 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 1.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.0 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 1.7 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.2 | 0.7 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 1.2 | GO:0035660 | MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
0.2 | 0.7 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 5.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 2.4 | GO:0071372 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 0.7 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 6.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.2 | 2.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.7 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.2 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.2 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 1.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 1.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 2.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 1.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 0.2 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.2 | 2.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 2.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 2.0 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 1.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 2.5 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 3.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.2 | 0.9 | GO:2000322 | regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
0.2 | 1.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 5.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.3 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 1.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.2 | 6.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 3.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 1.3 | GO:0007031 | peroxisome organization(GO:0007031) |
0.2 | 0.4 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.2 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 12.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.2 | 1.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 5.3 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.2 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 0.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
0.2 | 0.4 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.2 | 0.6 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 5.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 6.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 2.5 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 0.8 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.4 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 1.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 3.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 2.8 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 1.4 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.2 | 2.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 1.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 1.4 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 2.8 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 3.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 5.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 2.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.6 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.2 | 1.4 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 0.2 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.6 | GO:0051030 | snRNA transport(GO:0051030) |
0.2 | 0.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 1.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.2 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.2 | 1.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 4.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.2 | 2.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.6 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.2 | 1.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.6 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 0.6 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 0.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.3 | GO:0097324 | melanocyte migration(GO:0097324) |
0.2 | 2.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.9 | GO:0034397 | telomere localization(GO:0034397) |
0.2 | 5.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 2.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 2.6 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.2 | 3.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.2 | 0.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 1.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 0.5 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.2 | 0.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.2 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 1.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.2 | 1.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 3.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 2.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.5 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 0.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.9 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 6.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 1.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 2.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 1.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 3.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.2 | 0.2 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.2 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.2 | 0.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.2 | 0.3 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.2 | 1.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.8 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 1.3 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.2 | 1.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 3.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.5 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 1.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.2 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 2.4 | GO:0003170 | heart valve development(GO:0003170) |
0.2 | 0.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.4 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.1 | GO:0042711 | maternal behavior(GO:0042711) |
0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.5 | GO:1902949 | regulation of tau-protein kinase activity(GO:1902947) positive regulation of tau-protein kinase activity(GO:1902949) |
0.2 | 1.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.6 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.2 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 1.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.5 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 | 0.9 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.2 | 1.4 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.2 | 0.3 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.2 | 1.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.4 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.1 | 2.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:0072347 | response to anesthetic(GO:0072347) |
0.1 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 2.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 1.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 5.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.1 | 2.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 4.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 1.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 1.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.6 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 1.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 1.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 3.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.3 | GO:0021762 | substantia nigra development(GO:0021762) |
0.1 | 0.9 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 4.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 2.2 | GO:0021545 | cranial nerve development(GO:0021545) |
0.1 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.4 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.1 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 1.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 1.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 2.0 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.1 | 1.6 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.1 | 0.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.1 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.1 | GO:1903588 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 2.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 5.4 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 0.8 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 1.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 1.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 2.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.6 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.5 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 1.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.5 | GO:0000105 | histidine biosynthetic process(GO:0000105) |
0.1 | 2.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.1 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) |
0.1 | 0.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 0.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 1.1 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.1 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 1.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 2.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 1.1 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 2.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.7 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.4 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 2.0 | GO:0035909 | aorta morphogenesis(GO:0035909) |
0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 4.3 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 2.3 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.6 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 | 2.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 1.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 1.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 1.2 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.3 | GO:0006530 | asparagine catabolic process(GO:0006530) |
0.1 | 0.5 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.3 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 1.4 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 | 0.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 1.9 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 0.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 1.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.4 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 5.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 2.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.4 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.1 | 7.9 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.3 | GO:0042694 | muscle cell fate specification(GO:0042694) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.1 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 2.6 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 1.6 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.6 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 2.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 2.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.6 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 1.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.3 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 1.6 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 1.2 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 1.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 3.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 3.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.4 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 3.9 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 2.0 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.6 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 0.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.9 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 1.5 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.1 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 1.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 2.4 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 1.6 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.1 | 0.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.1 | 0.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.9 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.1 | 0.8 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.2 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.1 | 0.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.1 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 3.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.4 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.3 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 3.5 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 1.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 1.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.2 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.7 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.6 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.7 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 7.1 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.1 | 0.1 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.1 | 0.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 3.6 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 1.1 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.4 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 1.2 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 0.3 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.1 | 0.3 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.1 | 0.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 1.0 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.6 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.1 | 0.1 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.1 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 1.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.6 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.1 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.1 | 0.6 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 1.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 1.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.8 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 0.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 2.2 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 4.1 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.0 | 0.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 1.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.4 | GO:2000232 | positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.3 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.0 | 0.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.5 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 3.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.2 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 1.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 4.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.0 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.2 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 1.8 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.3 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.2 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) purine-containing compound transmembrane transport(GO:0072530) |
0.0 | 0.1 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.1 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.5 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0048686 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) snoRNA 3'-end processing(GO:0031126) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.1 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.7 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.0 | 0.0 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.0 | 0.2 | GO:0033292 | T-tubule organization(GO:0033292) |
0.0 | 0.4 | GO:0007043 | cell-cell junction assembly(GO:0007043) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.1 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.0 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.0 | 0.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 20.8 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
3.5 | 10.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
2.6 | 17.9 | GO:0005955 | calcineurin complex(GO:0005955) |
2.5 | 15.0 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
2.4 | 7.2 | GO:0034359 | mature chylomicron(GO:0034359) |
2.2 | 8.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
2.2 | 2.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
2.2 | 6.5 | GO:0018444 | translation release factor complex(GO:0018444) |
2.1 | 6.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.0 | 12.0 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
1.9 | 7.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
1.9 | 15.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.9 | 15.3 | GO:0005827 | polar microtubule(GO:0005827) |
1.9 | 5.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.6 | 42.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.6 | 7.8 | GO:0000938 | GARP complex(GO:0000938) |
1.5 | 10.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
1.5 | 12.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.5 | 13.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.5 | 22.8 | GO:0031209 | SCAR complex(GO:0031209) |
1.4 | 5.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.3 | 13.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.3 | 6.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.3 | 7.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.2 | 4.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
1.2 | 8.2 | GO:0072487 | MSL complex(GO:0072487) |
1.2 | 18.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.2 | 4.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.1 | 3.4 | GO:0090537 | CERF complex(GO:0090537) |
1.1 | 4.4 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 7.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.1 | 3.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.0 | 2.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.0 | 4.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.0 | 4.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
1.0 | 3.0 | GO:0032156 | septin cytoskeleton(GO:0032156) |
1.0 | 4.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.0 | 5.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.9 | 3.7 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.9 | 17.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 2.7 | GO:0044317 | rod spherule(GO:0044317) |
0.9 | 4.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.9 | 17.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 4.4 | GO:0034657 | GID complex(GO:0034657) |
0.9 | 2.6 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.9 | 11.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.9 | 18.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.9 | 2.6 | GO:0043291 | RAVE complex(GO:0043291) |
0.9 | 2.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.8 | 6.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.8 | 2.5 | GO:0016939 | kinesin II complex(GO:0016939) |
0.8 | 7.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.8 | 5.8 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 8.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.8 | 2.4 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.8 | 9.8 | GO:0008278 | cohesin complex(GO:0008278) |
0.8 | 7.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.8 | 4.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 11.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.8 | 0.8 | GO:0060187 | cell pole(GO:0060187) |
0.8 | 4.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.7 | 11.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.7 | 5.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.7 | 8.9 | GO:0001739 | sex chromatin(GO:0001739) |
0.7 | 13.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 4.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 53.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 5.0 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 9.2 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 0.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 2.0 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.7 | 4.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.7 | 7.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 2.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 15.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 8.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 7.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 1.9 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.6 | 4.3 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 4.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.6 | 6.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 6.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.6 | 3.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 16.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 3.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.6 | 2.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 2.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.5 | 5.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 9.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.5 | 6.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.5 | 2.2 | GO:0008623 | CHRAC(GO:0008623) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
0.5 | 3.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 10.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 10.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 1.5 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
0.5 | 5.5 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 2.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.5 | 4.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.5 | 9.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 1.9 | GO:0097447 | dendritic tree(GO:0097447) |
0.5 | 2.4 | GO:0043293 | apoptosome(GO:0043293) |
0.5 | 5.2 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 5.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 10.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 5.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.5 | 7.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.4 | 7.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 4.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 8.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 3.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 5.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 1.3 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.4 | 3.3 | GO:0031673 | H zone(GO:0031673) |
0.4 | 1.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 5.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 3.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 6.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 1.2 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 4.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 2.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.2 | GO:0070992 | translation initiation complex(GO:0070992) |
0.4 | 3.9 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 2.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 8.9 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 5.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.4 | 8.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 4.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.4 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 15.0 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 3.6 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 2.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.4 | 1.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 2.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 1.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.4 | 2.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 5.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 3.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 15.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.0 | GO:1903754 | cortical microtubule(GO:0055028) cortical microtubule plus-end(GO:1903754) cytoplasmic microtubule plus-end(GO:1904511) |
0.3 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 5.3 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 2.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 3.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 3.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 1.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 1.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 2.6 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.0 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.3 | 5.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 7.7 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 0.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 3.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.3 | 0.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.3 | 64.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.3 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 3.0 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.3 | 1.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 1.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 2.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 7.3 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 6.4 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 5.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 2.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 2.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 0.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 102.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.3 | 8.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 11.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.6 | GO:0071920 | cleavage body(GO:0071920) |
0.3 | 1.9 | GO:0000235 | astral microtubule(GO:0000235) |
0.3 | 3.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 63.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 3.6 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 2.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 6.9 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 2.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 9.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 0.8 | GO:0070985 | TFIIK complex(GO:0070985) |
0.3 | 1.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.3 | 2.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 2.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 5.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 5.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 1.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 3.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 9.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 29.9 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.2 | 28.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 3.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 4.6 | GO:0033646 | host intracellular part(GO:0033646) intracellular region of host(GO:0043656) |
0.2 | 1.8 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 2.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 7.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 9.1 | GO:0043034 | costamere(GO:0043034) |
0.2 | 1.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 12.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.2 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 1.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.2 | 4.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 1.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 11.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 12.1 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.6 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 3.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.2 | 3.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 9.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.6 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 3.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 2.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 6.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 1.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 4.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.2 | 4.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 3.5 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 3.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 1.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 1.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 2.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 5.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.2 | 4.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.6 | GO:0000786 | nucleosome(GO:0000786) |
0.2 | 15.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 1.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 2.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 8.2 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 25.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 5.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 2.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 0.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.7 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 5.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 2.5 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 15.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 28.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 4.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 93.2 | GO:0005768 | endosome(GO:0005768) |
0.1 | 5.7 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 8.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 2.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 35.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 2.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.7 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 11.6 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 221.9 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 6.6 | GO:0005814 | centriole(GO:0005814) |
0.1 | 2.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.4 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 3.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 1.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 3.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 5.6 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 2.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 2.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0043512 | inhibin A complex(GO:0043512) |
0.0 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 2.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 2.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 18.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 33.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 12.9 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 1.5 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 1.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.0 | 23.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.0 | 0.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 1.0 | GO:0031968 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.0 | 0.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.0 | GO:0060473 | cortical granule(GO:0060473) |
0.0 | 0.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 20.8 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
4.3 | 13.0 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
4.1 | 16.3 | GO:0031208 | POZ domain binding(GO:0031208) |
3.7 | 11.1 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
3.5 | 10.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
3.4 | 20.7 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
3.4 | 10.1 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
3.1 | 9.4 | GO:0019002 | GMP binding(GO:0019002) |
3.1 | 9.2 | GO:0008431 | vitamin E binding(GO:0008431) |
2.9 | 17.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.8 | 11.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.6 | 7.7 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
2.5 | 7.5 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
2.3 | 18.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
2.3 | 6.8 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
2.2 | 6.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.2 | 6.7 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
2.2 | 15.4 | GO:0002135 | CTP binding(GO:0002135) |
2.2 | 6.5 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
2.1 | 6.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
2.1 | 10.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
2.1 | 8.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.0 | 8.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
2.0 | 19.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.0 | 8.0 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.9 | 7.8 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.9 | 25.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.9 | 5.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
1.8 | 10.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.8 | 9.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
1.7 | 13.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.7 | 5.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.7 | 6.7 | GO:0036033 | mediator complex binding(GO:0036033) |
1.6 | 37.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.6 | 11.4 | GO:0097016 | L27 domain binding(GO:0097016) |
1.5 | 12.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.5 | 4.4 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
1.5 | 10.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.4 | 8.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.4 | 4.1 | GO:0070336 | forked DNA-dependent helicase activity(GO:0061749) flap-structured DNA binding(GO:0070336) |
1.4 | 4.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.3 | 4.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.3 | 4.0 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.3 | 12.9 | GO:0043559 | insulin binding(GO:0043559) |
1.3 | 5.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.3 | 7.6 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
1.3 | 6.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.2 | 9.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
1.2 | 15.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.2 | 4.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.2 | 1.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.2 | 4.7 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
1.2 | 10.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.2 | 4.6 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
1.1 | 3.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.1 | 3.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
1.1 | 12.4 | GO:0008494 | translation activator activity(GO:0008494) |
1.1 | 3.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.1 | 1.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.1 | 4.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.1 | 4.3 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
1.1 | 2.1 | GO:0032564 | dATP binding(GO:0032564) |
1.0 | 5.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.0 | 4.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.0 | 7.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.0 | 4.0 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
1.0 | 25.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.0 | 11.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.0 | 5.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.0 | 4.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.0 | 11.9 | GO:0071253 | connexin binding(GO:0071253) |
1.0 | 12.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 6.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.9 | 5.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.9 | 2.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 1.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.9 | 3.6 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.9 | 12.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.9 | 4.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.9 | 2.7 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.9 | 1.7 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.9 | 3.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.9 | 9.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.9 | 3.5 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.9 | 2.6 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.9 | 5.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.9 | 4.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.8 | 19.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.8 | 4.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.8 | 9.9 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 3.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.8 | 3.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.8 | 31.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.8 | 6.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.8 | 2.4 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.8 | 4.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.8 | 10.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.8 | 18.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 31.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 8.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.8 | 3.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.8 | 6.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.8 | 2.3 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
0.8 | 7.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 2.3 | GO:0010428 | methyl-CpNpG binding(GO:0010428) |
0.7 | 4.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 3.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.7 | 4.4 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.7 | 2.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.7 | 4.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 20.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.7 | 4.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.7 | 11.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.7 | 11.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 2.7 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.7 | 3.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 4.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 0.7 | GO:0015292 | uniporter activity(GO:0015292) |
0.7 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.7 | 20.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.7 | 2.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 2.0 | GO:0004135 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.7 | 9.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.7 | 5.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 14.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.6 | 17.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 11.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 11.0 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.6 | 17.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 2.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 1.9 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.6 | 22.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 1.8 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 3.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.6 | 34.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.6 | 3.0 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.6 | 13.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.8 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.6 | 9.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 2.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.6 | 2.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 5.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 2.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 1.7 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.6 | 41.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 2.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.6 | 2.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 1.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 3.9 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.5 | 4.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.5 | 2.2 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.5 | 3.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 3.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.5 | 9.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.5 | 1.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 12.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 2.1 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.5 | 11.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 6.7 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 3.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.5 | 2.5 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.5 | 7.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 11.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 10.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 1.5 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.5 | 3.0 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.5 | 2.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 5.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.5 | 11.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 10.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.5 | 3.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.5 | 6.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 6.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.5 | 2.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 3.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 1.8 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.5 | 10.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 0.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.5 | 9.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 2.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 14.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 5.8 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 51.7 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 1.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 5.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 2.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.4 | 1.3 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.4 | 1.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 2.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.4 | 4.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 3.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 3.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 1.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.3 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.4 | 1.7 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.4 | 2.1 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 2.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 2.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 1.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.4 | 2.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.4 | 2.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 19.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 1.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 2.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.4 | 131.1 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 2.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 1.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 1.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 1.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 8.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 4.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 3.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 5.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 2.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 1.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.4 | 1.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 23.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 2.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 2.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 1.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 8.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 2.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 3.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 0.7 | GO:0003896 | DNA primase activity(GO:0003896) |
0.4 | 10.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.1 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.4 | 1.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.3 | 4.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.0 | GO:0031370 | eukaryotic initiation factor 4G binding(GO:0031370) |
0.3 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 2.0 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.3 | 0.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 3.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 1.0 | GO:0005368 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.3 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 1.3 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.3 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 6.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 2.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 1.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.3 | 1.9 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.3 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 3.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 2.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.2 | GO:0005118 | sevenless binding(GO:0005118) |
0.3 | 1.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 1.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 1.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.3 | 3.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 5.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 8.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 0.9 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.3 | 1.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 0.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 3.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 4.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 2.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 2.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 4.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 20.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 0.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 1.5 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 1.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 16.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 1.2 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.3 | 4.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 3.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 15.5 | GO:0019003 | GDP binding(GO:0019003) |
0.3 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 3.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 0.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.3 | 7.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 5.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 5.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 2.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 1.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 0.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.3 | 0.8 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
0.3 | 3.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 0.8 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.3 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 4.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 34.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 2.9 | GO:0016151 | nickel cation binding(GO:0016151) |
0.3 | 2.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 2.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 1.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 1.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.3 | 1.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.3 | 3.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 2.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 2.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.7 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
0.2 | 4.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 2.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 1.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 3.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.2 | 0.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.7 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.2 | 4.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 6.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 3.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 3.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 1.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 3.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.7 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.2 | 3.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.9 | GO:0018455 | alcohol dehydrogenase [NAD(P)+] activity(GO:0018455) |
0.2 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.2 | 3.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 4.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 2.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 3.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 40.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 3.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 4.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.9 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 20.9 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 3.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 1.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 4.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.4 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 8.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 5.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 1.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.2 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.2 | 2.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 3.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 5.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 0.9 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.2 | 3.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.2 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.2 | 2.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.7 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.2 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.5 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.2 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 14.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 1.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 4.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.2 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.7 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 7.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.7 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.2 | 1.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 2.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 0.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.2 | 0.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.2 | 18.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 4.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 9.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 0.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.2 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 4.9 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.2 | 0.5 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 0.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.5 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.2 | 3.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 6.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 2.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.4 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 0.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 6.4 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.3 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
0.1 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 20.0 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 18.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 7.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 2.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.8 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
0.1 | 21.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.1 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 1.6 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 0.4 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 0.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 0.5 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 3.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 1.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.4 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 1.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 1.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 7.2 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 2.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 1.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 5.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 5.8 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.1 | 2.7 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.6 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 2.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.3 | GO:0004067 | asparaginase activity(GO:0004067) |
0.1 | 0.3 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 4.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 1.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 10.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 5.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 5.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 1.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 3.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 2.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 2.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 3.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 4.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 2.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 2.0 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 1.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 3.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 1.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 4.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 1.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 3.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 9.5 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.2 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
0.1 | 0.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.1 | 1.2 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.1 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 1.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 4.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 0.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.7 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 4.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.3 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.1 | 2.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.8 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.1 | 0.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.1 | 0.2 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.1 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 6.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.5 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 1.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 31.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 2.6 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.1 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 1.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 1.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.0 | 0.2 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.3 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 2.2 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 1.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 6.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 1.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 6.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.2 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.0 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.0 | 3.1 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 1.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) temperature-gated cation channel activity(GO:0097604) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0030272 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.1 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 12.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 5.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 55.5 | PID BMP PATHWAY | BMP receptor signaling |
0.9 | 12.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 60.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.7 | 31.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.7 | 1.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 14.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.7 | 4.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 49.8 | PID FOXO PATHWAY | FoxO family signaling |
0.6 | 18.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 35.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 2.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 4.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.5 | 14.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 35.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.5 | 12.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 20.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 29.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 19.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 15.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 14.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 30.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 14.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 28.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 10.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 27.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 18.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.4 | 29.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 5.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.4 | 1.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 5.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 5.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 4.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 2.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 7.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 17.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 6.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 9.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 2.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 5.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 5.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 13.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 10.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 8.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 9.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.3 | PID ATM PATHWAY | ATM pathway |
0.2 | 4.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 7.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 2.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 3.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 5.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 5.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 5.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 2.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 3.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 3.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 4.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 3.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 3.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 5.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 11.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.5 | 2.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.6 | 1.6 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.4 | 18.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.4 | 14.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.3 | 1.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.3 | 36.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.2 | 35.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 40.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.2 | 40.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.2 | 23.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.2 | 3.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.1 | 19.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.0 | 10.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.9 | 10.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.9 | 11.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.9 | 27.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.9 | 18.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.8 | 25.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 36.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 45.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.8 | 12.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 10.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 0.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.7 | 0.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 5.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 14.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 6.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.6 | 9.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 14.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 8.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 15.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 12.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 16.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 6.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 6.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.5 | 7.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.5 | 11.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 13.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 6.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 11.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 4.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 5.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 13.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 8.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 5.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 3.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 1.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 8.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 4.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 19.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 7.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 11.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 8.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 4.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 25.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 3.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 8.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 7.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 1.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 14.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 3.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 4.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 6.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 3.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 3.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 2.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 6.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 8.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 7.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 6.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 22.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 12.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 5.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 5.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 3.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 3.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 14.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 9.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 10.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 6.9 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.2 | 7.4 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.2 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 3.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 10.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 6.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 9.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 4.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 8.7 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 2.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 9.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 4.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 3.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 1.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 3.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 4.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 4.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.8 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 6.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 18.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 3.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.7 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 3.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.0 | 4.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.0 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 1.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |